Prospeo
Hero Section BackgroundHero Section Background
Oragen Therapeutics

Oragen Therapeutics Revenue

Biotechnology Research1-10 Employees

$

Oragen Therapeutics revenue & valuation

Annual revenue$171,110
Revenue per employee$86,000
Estimated valuation?$547,552
Total fundingNo funding

Key Contact at Oragen Therapeutics

Flag of FR

Thomas Stalder

Chief Technology Officer

Company overview

HeadquartersXX
Website
NAICS541714
Founded2025
Employees1-10

About Oragen Therapeutics

We are a preclinical-stage biotech company focused on developing revolutionary therapies to address Inflammatory Bowel Diseases. Harnessing the unique capabilities of our Genetic Medicines Oral Delivery platform we aim to overcome major limitations of current treatments and unlock the groundbreaking potential of Genetic Medicines in IBDs, driving transformative change in a field with critical medical needs.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Oragen Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Oragen Therapeutics has never raised funding before.

Frequently asked questions

Oragen Therapeutics is located in XX.
Oragen Therapeutics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
Oragen Therapeutics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Oragen Therapeutics was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.
Oragen Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles